Juif, Pierre-Eric
47  results:
Search for persons X
?
2

Phase I/Ib, open-label, multicenter, dose-escalation study ..:

Bauer, Todd M ; Santoro, Armando ; Lin, Chia-Chi...
Journal for ImmunoTherapy of Cancer.  11 (2023)  11 - p. e007353 , 2023
 
?
3

Lack of Effect of Cenerimod, a Selective S1P1 Receptor Modu..:

Juif, Pierre-Eric ; Mueller, Markus S. ; Charfi, Hakim.
International Journal of Molecular Sciences.  23 (2022)  23 - p. 14986 , 2022
 
?
4

PK/PD modeling of a clazosentan thorough QT study with hyst..:

Henrich, Andrea ; Juif, Pierre-Eric ; Dingemanse, Jasper.
Journal of Pharmacokinetics and Pharmacodynamics.  48 (2021)  2 - p. 213-224 , 2021
 
?
8

Cardiodynamic Interactions between Two S1P1 Receptor Modula..:

Juif, Pierre-Eric ; Ufer, Mike ; Dingemanse, Jasper
International Journal of Molecular Sciences.  20 (2019)  13 - p. 3232 , 2019
 
?
9

Pharmacokinetics, Pharmacodynamics, Tolerability, and Food ..:

Juif, Pierre-Eric ; Baldoni, Daniela ; Reyes, Maribel...
International Journal of Molecular Sciences.  18 (2017)  12 - p. 2636 , 2017
 
?
10

A pharmacokinetic drug–drug interaction study between selex..:

Juif, Pierre-Eric ; Boehler, Margaux ; Donazzolo, Yves..
European Journal of Clinical Pharmacology.  73 (2017)  9 - p. 1121-1128 , 2017
 
?
12

Absolute Bioavailability of Ponesimod, a Selective S1P1 Rec..:

Boehler, Margaux ; Juif, Pierre-Eric ; Hoch, Matthias.
European Journal of Drug Metabolism and Pharmacokinetics.  42 (2016)  1 - p. 129-134 , 2016
 
?
13

Effects of multiple-dose ponesimod, a selective S1P1 recept..:

Jurcevic, Stipo ; Juif, Pierre-Eric ; Hamid, Colleen...
Drug Design, Development and Therapy.  11 (2016)  - p. 123-131 , 2016
 
?
 
1-15